JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

A

133.13

-0.58%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

17.68 -5.4

Resumen

Variación precio

24h

Actual

Mínimo

17.23

Máximo

18.69

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

P/B

Media del Sector

48.528

90.422

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-2.91% downside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.13%

Próximas Ganancias

2 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

37M

405M

Apertura anterior

23.08

Cierre anterior

17.68

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

331 / 352 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 ene 2026, 22:31 UTC

Ganancias

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29 ene 2026, 22:05 UTC

Ganancias

Stryker Logs Higher 4Q Profit On Sales Gains

29 ene 2026, 21:54 UTC

Ganancias

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29 ene 2026, 21:36 UTC

Ganancias

Visa 1Q Sales Climb on Strong Holiday Shopping

29 ene 2026, 23:57 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29 ene 2026, 23:56 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29 ene 2026, 23:53 UTC

Adquisiciones, fusiones, absorciones

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29 ene 2026, 23:51 UTC

Ganancias

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29 ene 2026, 23:49 UTC

Charlas de Mercado

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29 ene 2026, 23:49 UTC

Charlas de Mercado

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29 ene 2026, 23:47 UTC

Charlas de Mercado

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29 ene 2026, 23:35 UTC

Ganancias

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29 ene 2026, 23:32 UTC

Charlas de Mercado

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29 ene 2026, 23:32 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

29 ene 2026, 23:15 UTC

Charlas de Mercado
Ganancias

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29 ene 2026, 22:27 UTC

Ganancias

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 ene 2026, 22:27 UTC

Ganancias

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29 ene 2026, 22:12 UTC

Ganancias

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 ene 2026, 21:55 UTC

Ganancias

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Financial Services Roundup: Market Talk

29 ene 2026, 21:50 UTC

Ganancias

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Health Care Roundup: Market Talk

29 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

29 ene 2026, 21:49 UTC

Ganancias

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29 ene 2026, 21:46 UTC

Ganancias

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29 ene 2026, 21:36 UTC

Ganancias

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29 ene 2026, 21:32 UTC

Ganancias

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29 ene 2026, 21:32 UTC

Ganancias

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29 ene 2026, 21:30 UTC

Ganancias

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29 ene 2026, 21:30 UTC

Ganancias

Apple 1Q Mac Rev $8.39B >AAPL

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

-2.91% descenso

Estimación a 12 Meses

Media 19 USD  -2.91%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

331 / 352 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat